February 2019 News & Announcements

February 2019
A new Texas Policy Evaluation Project (TxPEP) study shows that use of medication abortion, also known as “the abortion pill,” bounced back in Texas after a March 2016 label change by the US Food and Drug Administration (FDA). The label change impacted the use of mifepristone, one of the...
February 2019
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about the current administration’s sweeping changes to Title X. “On Friday, the Trump administration continued its attacks on people’s—and especially women...